We are live on ! Find out more
VTRS icon

Viatris

554 hedge funds and large institutions have $12.8B invested in Viatris in 2016 Q3 according to their latest regulatory filings, with 59 funds opening new positions, 222 increasing their positions, 202 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more repeat investments, than reductions

Existing positions increased: 222 | Existing positions reduced: 202

4% less funds holding

Funds holding: 577554 (-23)

9% less capital invested

Capital invested by funds: $14.1B → $12.8B (-$1.3B)

12% less call options, than puts

Call options by funds: $270M | Put options by funds: $306M

26% less first-time investments, than exits

New positions opened: 59 | Existing positions closed: 80

36% less funds holding in top 10

Funds holding in top 10: 2214 (-8)

Holders
554
Holders Change
-23
Holders Change %
-3.99%
% of All Funds
14.74%
Holding in Top 10
14
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-36.36%
% of All Funds
0.37%
New
59
Increased
222
Reduced
202
Closed
80
Calls
$270M
Puts
$306M
Net Calls
-$36.2M
Net Calls Change
-$93M

VTRS Hedge Fund Activity: Q3 2016 in Review

554 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Viatris (VTRS) for Q3 2016, worth a combined $12.8B — down 9.2% from $14.1B a quarter earlier.

Sellers outnumbered buyers: 80 funds closed out of VTRS and 59 opened new positions — a net loss of 21 holders — while 202 trimmed existing stakes and 222 added.

The largest buyer was Norges Bank, adding an estimated $178M. The largest seller was Fidelity Investments, cutting an estimated $151M.

  • 554 institutional investors held Viatris (VTRS) as of Q3 2016, down from 577 in Q2 2016.
  • Funds reported $12.8B of Viatris stock for Q3 2016, down 9.2% quarter-over-quarter.
  • 59 funds opened new Viatris positions in Q3 2016 and 80 closed out, a net change of -21 holders.
  • The largest Viatris buyer in Q3 2016 was Norges Bank, an estimated $178M added.
  • The largest Viatris seller in Q3 2016 was Fidelity Investments, an estimated $151M sold.

Based on aggregated 13F filings for Q3 2016.